首页> 外国专利> Evaluation kit evaluation method and substance, the screening method of the substance, as well as determination kit and method of determining the risk of developing or future existence of the onset of diabetic nephropathy

Evaluation kit evaluation method and substance, the screening method of the substance, as well as determination kit and method of determining the risk of developing or future existence of the onset of diabetic nephropathy

机译:评估试剂盒评估方法和物质,物质的筛选方法以及确定糖尿病肾病发作或将来存在风险的测定试剂盒和方法

摘要

Providing a set of technologies for identifying new biomarkers that reflect the risk of future diabetic nephropathy, using the biomarker. By ingestion of the test substance to the animal risk of future higher animal or develop diabetic nephropathy, and compared with a reference value for the concentration of the at least one marker substance eight in the body fluids of the animal, the test substance I will evaluate the effect of reducing the risk of future or improvement of diabetic nephropathy with is. It is also possible to capture the marker substance to a carrier which is immobilized a substance having an affinity for the marker substance, to calculate the concentration of the marker substance in a body fluid. Screening method for a substance using the evaluation method, and is also provided method of determining the risk of developing or future existence of the onset of diabetic nephropathy, which was used as an indicator the marker substance.
机译:使用生物标记物提供一套技术,用于识别反映未来糖尿病肾病风险的新生物标记物。通过将测试物质摄入可能会导致更高动物或发展成糖尿病性肾病的动物风险中,并与动物体液中至少一种标志物物质八的浓度的参考值进行比较,我将评估测试物质I具有降低未来或改善糖尿病性肾病风险的作用。也可以将标记物捕获到载体上,该载体被固定了对标记物具有亲和力的物质,以计算体液中标记物的浓度。使用该评价方法的物质的筛选方法,并且还提供了确定糖尿病性肾病发作或将来存在的风险的方法,其被用作标志物物质的指示剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号